FTC sues drug middlemen for allegedly inflating insulin prices
- Posted on September 20, 2024
- By CNBC
- 1 Views
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
